Medicamen Biotech Share price

MEDICAMEQ

Healthcare Small

388.05

4.25 (-1.08%)

NSE

BSE

Last updated on 25 Jul, 2025 | 15:31 IST

BUYSELL

Today's High

396.90

Today's Low

384.95

52 Week Low

375.05

52 Week High

630.00 The current prices are delayed, login to your account for live prices

Medicamen Biotech Chart

ChartIQ

TradingView

Medicamen Biotech Share Key Metrics

Volume

20819.00

Market Cap

526.31 CR

LTQ@LTP

13@388.05

ATP

389.57 Var Margin

24.44 %

Circuit Range

313.85-470.75

Delivery %

54.95 %

Value

81.10 L

ASM/GSM

No

Market Lot

1

Medicamen Biotech Futures & Options

Data Not Found

Medicamen Biotech Corporate Actions

Date	Agenda
2025-05-30	Audited Results & Final Dividend
2025-02-26	Preferential issue of shares
2025-02-11	Quarterly Results

Date	Record Date

Medicamen Biotech News

Medicamen Biotech shares zoom 20%, up 40% in two sessions

Apr 29 2024 12:16:53

NSE : 6278

BSE : 531146

ISIN : INE646B01010

MBL was incorporated as a public limited company under the Companies Act 1956 on December 22 1993. The certificate of commencement of business was obtained on January 31 1994. The company has jointly been promoted by Mr.V.Kumar Mr.Bal Kishan Gupta Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh.MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst Cadila Hindustan Ciba Purepharma Oboi Labs etc. and exporting to countries like Germany Russia Holland CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales.MBL has obtained permission for production of tablets capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited New Delhi and Pure Pharma Private Limited Indore respectively.

Medicamen Biotech Management

Name	Position
Mr. Rahul Bishnoi	Chairman
Mr. Ashwani Kumar Sharma	Non Executive Director
Dr. Vimal Kumar Shrawat	Non Executive Director
Mr. Sanjay Bansal	Non Executive Director
Mr. Suresh Kumar Singh	Non Executive Director

Chandan Healthcare Ltd.

247.05

-9.25 (3.61%)

Zim Laboratories Ltd.

113.50

-3.04 (2.61%)

Kaya Ltd.

422.40

-8.60 (2.00%)

Accent Microcell Ltd.

274.15

4.15 (1.54%)

Valiant Laboratories Ltd.

94.24

-3.97 (4.04%)

Medico Remedies Ltd.

40.55

-1.56 (3.70%)

Brooks Laboratories Ltd.

151.99

-3.11 (2.01%)

Medicamen Biotech FAQs

The Buying Price of Medicamen Biotech share is 388.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Medicamen Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Medicamen Biotech, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Medicamen Biotech shares is 75. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Medicamen Biotech shares is 2.12. Useful to assess the stock's value relative to its book value.

To assess Medicamen Biotech’s valuation compare Sector P/E, P/B which are 35.82 & 3.92 with sector averages, along with growth rates and financial metrics.

The Market Cap of Medicamen Biotech is 526.31 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Medicamen Biotech share price is 630.00 & 375.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.